Drug intelligence / Profile preview

acebrophylline (Lucky's Pharma)

Development stage
Unknown
Lead developer
Almirall
Modality
Small Molecules
Administration
Oral
01

Overview

Acebrophylline is an airway mucus regulator with anti-inflammatory and bronchodilating properties. It is chemically a conjugate of ambroxol and theophylline-7-acetate. The theophylline component acts as a bronchodilator by inhibiting phosphodiesterase (PDE), which increases intracellular cAMP levels and leads to smooth muscle relaxation. The ambroxol component acts as a mucolytic by increasing surfactant production and reducing mucus viscosity, thereby facilitating expectoration. Additionally, acebrophylline inhibits the release of inflammatory mediators such as leukotrienes and prostaglandins by inhibiting phospholipase A2. It is primarily indicated for the management of chronic obstructive pulmonary disease (COPD) and bronchial asthma.

Brand names
ABRON-SR
Other names
Acebrophylline SR 200ambroxol + theophylline-7-acetate
02

Targets

PLA2 (Phospholipase A2 group IID)PDE (Phosphodiesterase family)

Beyond the preview

Go deeper on acebrophylline (Lucky's Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acebrophylline (Lucky's Pharma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call